Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$257,588,056
+$15,008,489 QoQ
Shares Held
1,014,246
+2.2% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
1.50%
of 13F equity value
Holder Rank
#174
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026USS Investment Management Ltd holds $724,325,860 across 10 Drug Manufacturers - General names. JNJ ranks #1 (35.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
1,014,246 | $257,588,056 | |
| 2 | LLY |
ELI LILLY & Co
|
139,687 | $167,544,792 | |
| 3 | ABBV |
AbbVie Inc.
|
300,376 | $75,586,616 | |
| 4 | MRK |
Merck & Co., Inc.
|
432,343 | $55,556,075 | |
| 5 | AZN |
Astrazeneca PLC
|
255,043 | $48,361,253 | |
| 6 | AMGN |
Amgen Inc
|
96,817 | $35,059,372 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
225,951 | $28,546,649 | |
| 8 | PFE |
Pfizer Inc
|
999,888 | $24,077,303 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $257,588,056 | 1,014,246 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $242,579,567 | 992,389 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $245,086,746 | 1,184,280 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $218,537,866 | 1,178,610 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $180,032,677 | 1,178,610 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $195,174,774 | 1,176,886 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $199,342,183 | 1,378,386 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $224,192,831 | 1,383,394 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $202,415,960 | 1,384,893 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $242,293,611 | 1,531,662 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $243,151,859 | 1,551,307 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $191,232,342 | 1,227,816 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $169,563,984 | 1,024,432 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $105,239,265 | 678,963 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $117,687,939 | 666,221 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $101,498,835 | 621,320 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $144,862,005 | 816,078 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $152,483,552 | 860,371 | Shares | Sole | 2022-07-18 | |
| 2021-12-31 | $143,671,942 | 839,843 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $135,812,294 | 840,943 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $108,388,376 | 657,936 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $108,131,781 | 657,936 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $103,545,967 | 657,936 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $101,556,407 | 682,136 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $95,928,785 | 682,136 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $85,506,725 | 652,076 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||